Company news: GlaxoSmithKline

Share this article:
GlaxoSmithKline is readying another round of R&D cuts and giving its Research Triangle Park workforce a haircut, with plans to eliminate positions at its Neurosciences Medicine Development Center, according to the News & Observer of Raleigh, NC. Less than 50 R&D jobs are being eliminated nationwide, with fewer than half of those coming from Research Triangle Park and Philadelphia emerging largely unscathed. It's a drop in the bucket after years of deep cuts at the company, which has cut 22,000 jobs worldwide between 2007 and 2010, the newspaper reported.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.